NovaBridge Biosciences American Depositary Shares (NBP) Stock
NASDAQ · NBP
1.37
Fundamentals
Market cap
$159.59M
Price / Earnings ratio
-2.2x
Price / Sales ratio
N/A
Price / Book ratio
0.8x
Return on assets
-34.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news
No recent news
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral0
Buy1
Strong Buy0
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
No data available
About NovaBridge Biosciences American Depositary Shares
No description available.
SectorHealthcare
IndustryBiotechnology
Employees30
CEODr. Srishti Gupta M.D.
IPO DateJan 17, 2020
HeadquartersRockville, MD
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Wei Fu | Executive Chairman | 1982 |
| Mr. Ming Lei | Chief Financial Officer | 1997 |
| Mr. Sean Wuxiong Cao M.B.A., Ph.D. | Chief Business Development Officer & Director | 1967 |
| Dr. Srishti Gupta M.D. | CEO & Director | 1976 |
| Mr. Mark Hagler | President & Chief Commercial Officer | — |
| Mr. Tyler Ehler | Senior Director of Investor Relations | — |
| Ms. Liwei Lin | General Counsel & Board Secretary | 1988 |
| Dr. Cong Xu M.D., Ph.D. | Senior VP and Head of R&D Center of Excellence | 1985 |
| Dr. Phillip Dennis M.D., Ph.D. | Chief Medical Officer | 1963 |
Fundamentals
Valuation
Market cap$159.59M
Price-to-sales ratioN/A
Price-to-book value0.84
Price-earnings ratio-2.20
Return on Equity-38.00%
Return on SalesN/A
Return on Assets-34.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.69
Income Statement
Average volume291,022
EBITDA$-74.45M
1 year high (52w)$5.19
1 year low (52w)$1.43
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
1 Wall Street Analyst Ratings
BUY
100% Buy
0% Hold
0% Sell
Target price
$9.00
Est return
561.76%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +8.8 | -18.3 | +3.6 | |||||||||
| 2026 | -22.5 | -4.4 | -28.7 | +0.4 | -22.7 | +14.0 | -19.6 | +13.0 | -20.2 |



